The European Commission (EC) has granted marketing authorisation for Truberzi (eluxadoline) from Allergan, in Europe. Truberzi is an oral medication...
Truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS-D).
Eluxadoline (Truberzi) is an orally administered, minimally absorbed agent that acts locally in the gastrointestinal tract as a mixed µ-opioid receptor agonist and δ-opioid receptor antagonist.